A meta-analysis of arrhythmia endpoints in randomized controlled trials of transendocardial stem cell injections for chronic ischemic heart disease.

Gilson C FernandesAmanda D F FernandesManuel RiveraAisha KhanIvonne H SchulmanLitsa K LambrakosRobert J MyerburgJeffrey J GoldbergerJoshua M HareRaul D Mitrani

Published in: Journal of cardiovascular electrophysiology (2019)

Nonskeletal myoblast transendocardial cell therapy was associated with a significantly lower risk of SCD or resuscitated SCA compared to control, with no proarrhythmic effects.

Keyphrases

cell therapy
stem cells
randomized controlled trial
cardiac arrest
mesenchymal stem cells
ultrasound guided
drug induced
double blind